Barely Significant
← all excerpts

Perspectives on Immunotherapy of Metastatic Colorectal Cancer.

Front Oncol · 2021 · PMC8219967 · PMID 34178645

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

showed a trendp = 0.07so close (0.05 < p ≤ 0.1)
found that patients responded to bevacizumab showed a trend of increasing CD3 (p = 0.07) and CD4 (p = 0.05) ( 94 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.